Current and Emerging Tools for Hepatocellular Carcinoma Surveillance

por Adeniji, Nia, Dhanasekaran, Renumathy
Publicado 2021

Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics

por Dhanasekaran, Renumathy, Limaye, Alpna, Cabrera, Roniel
Publicado 2012

Chinese Skullcap in Move Free Arthritis Supplement Causes Drug Induced Liver Injury and Pulmonary Infiltrates

por Dhanasekaran, Renumathy, Owens, Victoria, Sanchez, William
Publicado 2013

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances

por Dhanasekaran, Renumathy, Bandoh, Salome, Roberts, Lewis R.
Publicado 2016

Rare Case of Adult Undifferentiated (Embryonal) Sarcoma of the Liver Treated with Liver Transplantation: Excellent Long-Term Survival

por Dhanasekaran, Renumathy, Hemming, Alan, Salazar, Elaine, Cabrera, Roniel
Publicado 2012

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B

por Sachar, Yashasavi, Brahmania, Mayur, Dhanasekaran, Renumathy, Congly, Stephen E.
Publicado 2021

Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases

por Adeniji, Nia, Carr, Rotonya M., Aby, Elizabeth S., Catana, Andreea M., Wegermann, Kara, Dhanasekaran, Renumathy
Publicado 2021

Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma

por Lai, Ian, Swaminathan, Srividya, Baylot, Virginie, Mosley, Adriane, Dhanasekaran, Renumathy, Gabay, Meital, Felsher, Dean W.
Publicado 2018

One world, one pandemic, many guidelines: management of liver diseases during COVID-19

por Bollipo, Steven, Kapuria, Devika, Rabiee, Atoosa, Ben-Yakov, Gil, Lui, Rashid N, Lee, Hye Won, Kumar, Goutham, Siau, Keith, Turnes, Juan, Dhanasekaran, Renumathy
Publicado 2020

Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma

por DHANASEKARAN, RENUMATHY, HEMMING, ALAN W., ZENDEJAS, IVAN, GEORGE, THOMAS, NELSON, DAVID R., SOLDEVILA-PICO, CONSUELO, FIRPI, ROBERTO J., MORELLI, GIUSEPPE, CLARK, VIRGINIA, CABRERA, RONIEL
Publicado 2013

Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC)

por Dhanasekaran, Renumathy, Gabay-Ryan, Meital, Baylot, Virginie, Lai, Ian, Mosley, Adriane, Huang, Xinqiang, Zabludoff, Sonya, Li, Jian, Kaimal, Vivek, Karmali, Priya, Felsher, Dean W.
Publicado 2017

YAP-associated chromosomal instability and cholangiocarcinoma in mice

por Rizvi, Sumera, Fischbach, Samantha R., Bronk, Steven F., Hirsova, Petra, Krishnan, Anuradha, Dhanasekaran, Renumathy, Smadbeck, James B., Smoot, Rory L., Vasmatzis, George, Gores, Gregory J.
Publicado 2017

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC

por Dhanasekaran, Renumathy, Park, Jangho, Yevtodiyenko, Alekesey, Bellovin, David I., Adam, Stacey J., KD, Anand Rajan, Gabay, Meital, Fernando, Hanan, Arzeno, Julia, Arjunan, Vinodhini, Gryanzov, Sergei, Felsher, Dean W.
Publicado 2020

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites

por Alshuwaykh, Omar, Cheung, Amanda, Goel, Aparna, Kwong, Allison, Dhanasekaran, Renumathy, Ghaziani, T. Tara, Ahmed, Aijaz, Daugherty, Tami, Dronamraju, Deepti, Kumari, Radhika, Nguyen, Mindie, Kim, W. Ray, Kwo, Paul Yien
Publicado 2022

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy

por Alshuwaykh, Omar, Daugherty, Tami, Cheung, Amanda, Goel, Aparna, Dhanasekaran, Renumathy, Ghaziani, T. Tara, Ahmed, Aijaz, Dronamraju, Deepti, Kumari, Radhika, Kwong, Allison, Nguyen, Mindie, Kim, W. Ray, Kwo, Paul Yien
Publicado 2022

MYC functions as a switch for natural killer cell-mediated immune surveillance of lymphoid malignancies

por Swaminathan, Srividya, Hansen, Aida S., Heftdal, Line D., Dhanasekaran, Renumathy, Deutzmann, Anja, Fernandez, Wadie D. M., Liefwalker, Daniel F., Horton, Crista, Mosley, Adriane, Liebersbach, Mariola, Maecker, Holden T., Felsher, Dean W.
Publicado 2020

MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity

por Dhanasekaran, Renumathy, Baylot, Virginie, Kim, Minsoon, Kuruvilla, Sibu, Bellovin, David I, Adeniji, Nia, Rajan KD, Anand, Lai, Ian, Gabay, Meital, Tong, Ling, Krishnan, Maya, Park, Jangho, Hu, Theodore, Barbhuiya, Mustafa A, Gentles, Andrew J, Kannan, Kasthuri, Tran, Phuoc T, Felsher, Dean W
Publicado 2020

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation

por Alshuwaykh, Omar, Kwong, Allison, Goel, Aparna, Cheung, Amanda, Dhanasekaran, Renumathy, Ahmed, Aijaz, Daugherty, Tami, Dronamraju, Deepti, Kumari, Radhika, Kim, W. Ray, Nguyen, Mindie H., Esquivel, Carlos O., Concepcion, Waldo, Melcher, Marc, Bonham, Andy, Pham, Thomas, Gallo, Amy, Kwo, Paul Yien
Publicado 2020

MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint

por Smith, Benjamin A. H., Deutzmann, Anja, Correa, Kristina M., Delaveris, Corleone S., Dhanasekaran, Renumathy, Dove, Christopher G., Sullivan, Delaney K., Wisnovsky, Simon, Stark, Jessica C., Pluvinage, John V., Swaminathan, Srividya, Riley, Nicholas M., Rajan, Anand, Majeti, Ravindra, Felsher, Dean W., Bertozzi, Carolyn R.
Publicado 2023

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry

por Moon, Andrew M., Webb, Gwilym J., Aloman, Costica, Armstrong, Matthew J., Cargill, Tamsin, Dhanasekaran, Renumathy, Genescà, Joan, Gill, Upkar S., James, Theodore W., Jones, Patricia D., Marshall, Aileen, Mells, George, Perumalswami, Ponni V., Qi, Xiaolong, Su, Feng, Ufere, Nneka N., Barnes, Eleanor, Barritt, A. Sidney, Marjot, Thomas
Publicado 2020